Opening book details…
Can I read Anti-Angiogenesis Strategies in Cancer Therapies on EtoBox?
Anti-Angiogenesis Strategies in Cancer Therapies by Shaker Mousa, Paul Davis (eds.) is a medicine available to read on EtoBox.
What is Anti-Angiogenesis Strategies in Cancer Therapies about?
<p><i>Anti-angiogenesis Strategies in Cancer Therapeutics</i> provides a detailed look at the current status and future directions in the discovery and development of novel anti-angiogenesis strategies in oncology. This book highlights the different mechanisms involved in the modulation of angiogenesis, including inflammation, thrombosis, and microRNA, and shows how nanotechnology can further enhance the potential of existing and new anti-angiogenesis approaches.</p> <p>Written for industry scie
Who reads Anti-Angiogenesis Strategies in Cancer Therapies?
It is typically read by working professionals who need an authoritative practice reference.
Common subject areas: medicine, law, business, engineering.
- Author
- Shaker Mousa, Paul Davis (eds.)
- Publisher
- Elsevier Science & Technology Books; Academic Press
- Published
- 2016
- Language
- EN
- ISBN
- 9780128025765
- Category
- medicine
- Subjects
- Medical, Pharmacology, Oncology
- Updated
- 2026-03-25
Other editions & translations
More by Shaker Mousa, Paul Davis (eds.)
Browse all works by Shaker Mousa, Paul Davis (eds.)
Similar books
- Nanoparticles in Angiogenesis and Cancer — Sudip Mukherjee; Vijay Sagar Madamsetty (2022)
- Resistance to Targeted Therapies in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics, 16) — Jenifer R. Prosperi (2017)
- Angiogenesis in Brain Tumors (Cancer Treatment and Research, 117) — Sybill Patan (auth.), Matthias Kirsch, Peter McL. Black (2004)
- Resistance to Proteasome Inhibitors in Cancer: Molecular Mechanisms and Strategies to Overcome Resistance (Resistance to Targeted Anti-Cancer Therapeutics) — Q. Ping Dou (2014)
- Progress In Anti-cancer Chemotherapy (v. 3) — A. U. Buzdar, C. A. Brunelli, L. A. Zwelling (auth.), Gabriel N. Hortobagyi, David Khayat (1999)
- Resistance to Molecular Therapies for Hepatocellular Carcinoma (Resistance to Targeted Anti-Cancer Therapeutics (13)) — Augusto Villanueva (2017)